Amber S. Kleckner

2.5k total citations · 1 hit paper
61 papers, 1.3k citations indexed

About

Amber S. Kleckner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Amber S. Kleckner has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 22 papers in Physiology. Recurrent topics in Amber S. Kleckner's work include Cancer survivorship and care (27 papers), Cancer-related cognitive impairment studies (20 papers) and Nutrition and Health in Aging (13 papers). Amber S. Kleckner is often cited by papers focused on Cancer survivorship and care (27 papers), Cancer-related cognitive impairment studies (20 papers) and Nutrition and Health in Aging (13 papers). Amber S. Kleckner collaborates with scholars based in United States, Australia and Germany. Amber S. Kleckner's co-authors include Ian R. Kleckner, Luke J. Peppone, Karen M. Mustian, Charles E. Heckler, Tenbroeck Smith, Barbara F. Piper, Catherine M. Alfano, Lisa K. Sprod, Suzanne M. Miller and Corinne R. Leach and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Amber S. Kleckner

55 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue

2017 570 citations Karen M. Mustian, Charles E. Heckler et al. profile →

Peers

Countries citing papers authored by Amber S. Kleckner

Since Specialization

Citations

This map shows the geographic impact of Amber S. Kleckner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber S. Kleckner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber S. Kleckner more than expected).

Fields of papers citing papers by Amber S. Kleckner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amber S. Kleckner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber S. Kleckner. The network helps show where Amber S. Kleckner may publish in the future.

Co-authorship network of co-authors of Amber S. Kleckner

This figure shows the co-authorship network connecting the top 25 collaborators of Amber S. Kleckner. A scholar is included among the top collaborators of Amber S. Kleckner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amber S. Kleckner. Amber S. Kleckner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dietary intake of live microbes is inversely associated with fatigue and modified by serum folate among adults aged 40 years or more 2026 ·Maturitas ·(unknown), Amber S. Kleckner, (unknown), (unknown), Alice S. Ryan, (unknown)	0
2	Blood Clock Correlation Distance (BloodCCD) as a novel marker to detect circadian rhythm disruption in cancer survivors with insomnia 2025 ·PubMed ·Brian J. Altman, Po‐Ju Lin, (unknown), (unknown), (unknown), Chin‐Shang Li, (unknown), (unknown), Amelia Clark, (unknown), (unknown), Amber S. Kleckner, Ian R. Kleckner, Nikesha Gilmore, Benjamin Esparaz, (unknown), Alison Conlin, Gianni Monaco, Jacob Hughey, Karen M. Mustian	1
3	High‐dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCT 2024 ·Cancer ·Luke J. Peppone, Amber S. Kleckner, Chunkit Fung, J. Edward Puzas, (unknown), Eva Culakova, Julia E. Inglis, Charles Kamen, Jonathan W. Friedberg, Michelle C. Janelsins, Karen M. Mustian, Charles E. Heckler, Supriya G. Mohile	6
4	Plant-Based Diets and Their Associations with Physical Performance in the Baltimore Longitudinal Study of Aging 2024 ·Nutrients ·Galya Bigman, Marius Emil Rusu, Amber S. Kleckner, John D. Sorkin, Yichen Jin, Sameera A. Talegawkar, Toshiko Tanaka, Luigi Ferrucci, Alice S. Ryan	2
5	Identifying Nutritional Inequities of Patients with Cancer Residing in Food Deserts 2024 ·Advances in Radiation Oncology ·Loredana Lepore, (unknown), (unknown), (unknown), (unknown), Amber S. Kleckner, Søren M. Bentzen, Pranshu Mohindra, Melissa A.L. Vyfhuis	0
6	Digitizing Survivorship Care Plans Through the POST-Treatment Health Outcomes of Cancer Survivors (POSTHOC) Mobile App: Protocol for a Phase II Randomized Controlled Trial 2024 ·JMIR Research Protocols ·(unknown), (unknown), (unknown), Dana C. Deighton, (unknown), (unknown), (unknown), Cynthia L. Renn, (unknown), Aaron T. Winder, Shijun Zhu, Ian R. Kleckner, Amber S. Kleckner	1
7	Nutritional Counseling During Chemotherapy Treatment: A Systematic Review of Feasibility, Safety, and Efficacy 2024 ·Current Oncology ·(unknown), (unknown), (unknown), (unknown), Gautam G. Rao, Ian R. Kleckner, Brenton J. Baguley, Amber S. Kleckner	1
8	Mediterranean-style dietary interventions in adults with cancer: a systematic review of the methodological approaches, feasibility, and preliminary efficacy 2024 ·European Journal of Clinical Nutrition ·(unknown), (unknown), (unknown), (unknown), Elena S. George, Amber S. Kleckner, Brenton J. Baguley	7
9	Intermittent fasting interventions to leverage metabolic and circadian mechanisms for cancer treatment and supportive care outcomes 2023 ·JNCI Monographs ·Faiza Kalam, Dara James, (unknown), Michael F. Coleman, (unknown), Elizabeth M. Cespedes Feliciano, Stephen D. Hursting, Dorothy D. Sears, Amber S. Kleckner	23
10	Preliminary evaluation of novel Bodily Attention Task to assess the role of the brain in chemotherapy-induced peripheral neurotoxicity (CIPN) 2023 ·Behavioural Brain Research ·(unknown), (unknown), Amber S. Kleckner, Susan G. Dorsey, Shijun Zhu, Madalina E. Tivarus, Shelli R. Kesler, (unknown), Ian R. Kleckner	3
11	Dietary Composition, Meal Timing, and Cancer-Related Fatigue: Insights From the Women’s Healthy Eating and Living Study 2023 ·Cancer Nursing ·Amber S. Kleckner, Ian R. Kleckner, Cynthia L. Renn, (unknown), Alice S. Ryan, Shijun Zhu	1
12	Serum Carotenoids and Cancer-Related Fatigue: An Analysis of the 2005–2006 National Health and Nutrition Examination Survey 2022 ·Cancer Research Communications ·Amber S. Kleckner, Edwin van Wijngaarden, Todd A. Jusko, Ian R. Kleckner, Po‐Ju Lin, Karen M. Mustian, Luke J. Peppone	7
13	Mechanisms, Mediators, and Moderators of the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy 2022 ·Cancers ·(unknown), Susanna B. Park, Fiona Streckmann, Joachim Wiskemann, Nimish Mohile, Amber S. Kleckner, Luana Colloca, Susan G. Dorsey, Ian R. Kleckner	32
14	Communication About Fall Risk in Community Oncology Practice: The Role of Geriatric Assessment 2022 ·JCO Oncology Practice ·(unknown), Lianlian Lei, Huiwen Xu, Kah Poh Loh, Megan Wells, (unknown), Erika Ramsdale, Amber S. Kleckner, Karen M. Mustian, Richard F. Dunne, (unknown), James D. Bearden, Brian L. Burnette, Mary Whitehead, Supriya G. Mohile, Tanya M. Wildes	5
15	The Effects of a Mediterranean Diet Intervention on Cancer-Related Fatigue for Patients Undergoing Chemotherapy: A Pilot Randomized Controlled Trial 2022 ·Cancers ·Amber S. Kleckner, (unknown), Ian R. Kleckner, Allison Magnuson, Andrea M. Amitrano, Eva Culakova, Michelle Shayne, Colleen S. Netherby, (unknown), Michelle C. Janelsins, Karen M. Mustian, Luke J. Peppone	22
16	Nutritional Status Predicts Fatty Acid Uptake from Fish and Soybean Oil Supplements for Treatment of Cancer-Related Fatigue: Results from a Phase II Nationwide Study 2021 ·Nutrients ·Amber S. Kleckner, Eva Culakova, Ian R. Kleckner, Elizabeth Belcher, Wendy Demark‐Wahnefried, Elizabeth Parker, Gilbert D. A. Padula, (unknown), Michelle C. Janelsins, Karen M. Mustian, Luke J. Peppone	10
17	Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis 2021 ·Breast Cancer Research and Treatment ·AnnaLynn M. Williams, (unknown), Charles E. Heckler, Debra L. Barton, (unknown), Jodi Geer, Amber S. Kleckner, Shaker R. Dakhil, Jerry W. Mitchell, Karen M. Mustian, Luke J. Peppone, Victor Kipnis, Charles Kamen, Ann M. O’Mara, Michelle C. Janelsins	39
18	Health related quality of life in adult cancer survivors: Importance of social and emotional support 2021 ·Cancer Epidemiology ·(unknown), Vinay K. Cheruvu, Nikesha Gilmore, Amber S. Kleckner, (unknown), (unknown), Elizabeth Belcher, (unknown)	16
19	Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer 2021 ·Journal of Neuroimmunology ·Michelle C. Janelsins, Lianlian Lei, (unknown), Amber S. Kleckner, Sarah L. Kerns, Nikesha Gilmore, Elizabeth Belcher, Bryan D. Thompson, (unknown), Judith O. Hopkins, (unknown), (unknown), Eva Culakova	15
20	Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT 2020 ·Nutrition and Cancer ·Julia E. Inglis, I. Diana Fernandez, Edwin van Wijngaarden, Eva Culakova, (unknown), Amber S. Kleckner, Po‐Ju Lin, Karen M. Mustian, Luke J. Peppone	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact